1.Effects of Closure of the Arteriovenous Fistula on Left Ventricular Mass and Function in Kidney Transplantation Patients.
San KIM ; Jung Yun MOON ; Jung Eun HUH ; Jeoung Myung AHN ; Hyeon Gook LEE ; Kyoung Im CHO ; Tae Ik KIM
Journal of Cardiovascular Ultrasound 2007;15(1):8-12
BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality in kidney transplantion recipients. Enhanced cardiac load by the persistence of functioning AVF in posttransplant period is associated with LV hypertrophy and may adversely influence cardiac outcome. METHODS: To investigate the impact of AVF on LV mass and function in kidney transplant recipients, 46 patients with functioning AVF were randomly assigned to surgical closure of AVF (fistular closing group, FC, n=23) or maintenance of fistula (fistular maintenance group, FM, n=23). Serum creatinine of all participants was stable(1.4+/-0.3). Mean age was 46+/-11. Mean posttransplant month was 78+/-53 (12-161). Echocardiography and determination of N-terminal pro-BNP, cTnT and CRP were done at 0, 1 and 6 months in group 1 (FC), and at 0 and 6 months in group 2 (FM). RESULTS: Baseline echocardiographic indices of systolic and diastolic LV function such as EF, E/A, E/E' and Tei index were not significantly different between groups. In patients whose AVF was surgically closed, LV mass (247.7+/-76.8 to 235.2+/-66.5, p=0.015) and LV mass index (144.0+/-10.1 to 137.1+/-8.6, p=0.02) significantly reduced at one month after closure, and no further significant change was observed at 6 months. In two groups no significant change in LV systolic and diastolic performance indices were observed. BNP, cTnT and CRP did not differ between groups in baseline value and did not change after closure. CONCLUSION: We conclude that the persistence of functioning AVF in kidney transplantation recipients is associated with LVH, and which can be reduced by closure of fistula. As LVH is one of major determinants of cardiovascular outcome in transplant patients as well as in general population, it would be prudent to close the fistula in patients with stable graft function.
Arteriovenous Fistula*
;
Cardiovascular Diseases
;
Creatinine
;
Echocardiography
;
Fistula
;
Humans
;
Hypertrophy
;
Hypertrophy, Left Ventricular
;
Kidney Transplantation*
;
Kidney*
;
Mortality
;
Transplantation
;
Transplants
2.Clinical Characteristics and Etiology of Travelers' Diarrhea among Korean Travelers Visiting South-East Asia.
Ji Yong AHN ; Jin Won CHUNG ; Kyu Jin CHANG ; Myung Hwan YOU ; Jin Sung CHAI ; Young A KANG ; Seong Han KIM ; Hyesook JEOUNG ; Doosung CHEON ; Ahyong JEOUNG ; Eun Suk CHOI
Journal of Korean Medical Science 2011;26(2):196-200
The morbidity of travelers' diarrhea (TD) is still high. This study examined the incidence of common pathogens and characteristics of TD among Korean travelers who visited South-East Asian countries. We performed a prospective study involving 479 Korean travelers with diarrheal disease from February 2009 to April 2009 and stool samples were examined and questionnaire surveys were done after arrival. Enterotoxigenic Escherichia coli (ETEC) was found in 36.0% of TD cases, as were the following: Enteroaggregative Escherichia coli (EAEC) in 27.0%, Vibrio parahaemolyticus in 13.1%, and Norovirus in 11.5%. The detected rate of classic TD was higher in men (P = 0.007), in patients who had a shorter duration trip (P = 0.023) and in patients who drank more than 1 liter of water per day (P = 0.037). Positive stool culture rates were higher in men (P = 0.005), in hospitalized patients (P = 0.013). and in those who consumed impure water or raw foods (P = 0.033). A higher severity of disease corresponded to a significantly higher culture positivity rate (P = 0.029). We should consider the possibility of other pathogens in addition to ETEC in patients with TD who visit South-East Asia. Travelers need to educate about risk factors associated with TD.
Adolescent
;
Adult
;
Aged
;
Asia, Southeastern/epidemiology
;
*Asian Continental Ancestry Group
;
Caliciviridae Infections/epidemiology/virology
;
Child
;
Diarrhea/epidemiology/*etiology/microbiology/virology
;
Escherichia coli/isolation & purification/pathogenicity
;
Escherichia coli Infections/epidemiology/microbiology
;
Feces/microbiology/virology
;
Female
;
Humans
;
Male
;
Middle Aged
;
Norovirus/isolation & purification/pathogenicity
;
Prospective Studies
;
Questionnaires
;
Republic of Korea
;
Risk Factors
;
*Travel
;
Travel Medicine
;
Vibrio parahaemolyticus/isolation & purification/pathogenicity
;
Young Adult
3.Effects of Combined Therapy with Ezetimibe Plus Simvastatin After Drug-Eluting Stent Implantation in a Porcine Coronary Restenosis Model.
Jung Sun CHO ; Myung Ho JEONG ; Doo Sun SIM ; Young Joon HONG ; Kyung Seob LIM ; Jung Ha KIM ; Hyoung Doo KIM ; Ju Yeal BAEK ; Hee Jeoung YOON ; Sung Ho HER ; Seung Won JIN ; Ju Han KIM ; Youngkeun AHN ; Jeong Gwan CHO ; Jong Chun PARK ; Jung Chaee KANG
Journal of Korean Medical Science 2010;25(5):716-722
The aim of this study was to examine the anti-proliferative and anti-inflammatory effects of ezetimibe/simvastatin (E/S) after drug-eluting stent (DES) implantation in a porcine coronary restenosis model. Pigs were randomized into two groups in which the coronary arteries (23 pigs) had DES. Stents were deployed with oversizing (stent/artery ratio 1.3:1) in porcine coronary arteries. Fifteen pigs were taken 10/20 mg of E/S and eight pigs were not taken E/S. Histopathologic analysis was assessed at 28 days after stenting. In neointima, most inflammatory cells were lymphohistiocytes. Lymphohistiocyte count was not different between two groups (337+/-227 vs. 443+/-366 cells, P=0.292), but neointima area was significantly smaller (1.00+/-0.49 mm2 vs. 1.69+/-0.98 mm2, P=0.021) and percent area stenosis was significantly lower (23.3+/-10% vs. 39+/-19%, P=0.007) in E/S group compared with control group. There were no significant differences in fibrin score (1.99+/-0.79 vs. 1.81+/-0.88, P=0.49), endothelial score (1.75+/-0.66 vs. 1.80+/-0.59, P=0.79), and the percent of endothelium covered lumen (43+/-21% vs. 45+/-21%, P=0.84) between E/S group and control group. Combined therapy with ezetimibe and simvastatin inhibits neointimal hyperplasia, but does not inhibit inflammatory infiltration and arterial healing after DES implantation in a porcine coronary restenosis model.
Animals
;
Anticholesteremic Agents/administration & dosage
;
Azetidines/*administration & dosage
;
Coronary Restenosis/diagnosis/drug therapy/*etiology
;
*Disease Models, Animal
;
Drug Combinations
;
Drug Implants/administration & dosage
;
Drug-Eluting Stents/*adverse effects
;
Female
;
Graft Occlusion, Vascular/diagnosis/*drug therapy/*etiology
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage
;
Simvastatin/*administration & dosage
;
Swine
;
Treatment Outcome